Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like <b>CapsoVision</b> Enhances CapsoCam Plus Capsule Endoscopy System With CapsoCloud September 7, 2017 Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device August 1, 2017 On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017
Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device August 1, 2017
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017
